This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages without signing in

Early/disseminated infection

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Dissemination of the infection may occur through the skin, lymph or blood vessels (1). Weeks or months later if the rash is untreated:

  • 8% develop cardiac features:
    • myopericarditis, often in young males
    • and/or conduction defects - a PR interval of greater than 0.3 ms may herald complete heart block
  • 15% get neurological manifestations (neuroborreliosis), which usually occur within four weeks of the initial illness and resolve over 3 months. It is the most common complication of lyme disease in UK and may include (2):
    • meningoradiculoneuritis (Bannwarth's syndrome)
    • meningitis
    • cranial neuritis - usually VII, with palsy - very hard to distinguish from Bell's palsy
    • radicular neuritis
  • 60% get brief attacks of arthritis, and oligoarticular arthritis usually of the large joints, particularly the knee, may occur there can be migratory joint or muscle pain, with or without joint swelling (3).

Other stage II features include:

  • secondary erythema chronicum migrans (3)
  • eye disorders - conjunctivitis, iridocyclitis, choroiditis, optic neuropathy with papilloedema
  • hepatomegaly
  • hepatitis
  • very rarely, a dry cough or testicular swelling

Reference:


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.